ENESTfreedom 144-Week Update: Long-Term Treatment-Free Remission (TFR) Following Frontline Nilotinib in Patients with Chronic Myeloid Leukemia in Chronic Phase (CML-CP)

Authors :: Valentín García Gutiérrez
Suddhasatta Acharyya
Bruno Martino
Manu Sondhi
Véronique Bédoucha
Eibhlin Conneally
Giuseppe Saglio
Andrzej Hellmann
Philipp le Coutre
Tamás Masszi
Jerald P. Radich
Susanne Saussele
Norbert Gattermann
Francis J. Giles
Shalini Chaturvedi
Jesper Stentoft
Andreas Hochhaus
David M. Ross
María Teresa Gómez Casares
Source :: Clinical Lymphoma Myeloma and Leukemia. 18:S226
Publication Year :: 2018
Publisher :: Elsevier BV, 2018.

Subjects :: 0301 basic medicine
Oncology
Cancer Research
medicine.medical_specialty
Long term treatment
business.industry
Myeloid leukemia
Hematology
03 medical and health sciences
030104 developmental biology
0302 clinical medicine
Nilotinib
030220 oncology & carcinogenesis
Internal medicine
Medicine
In patient
Chronic phase CML
business
medicine.drug

Tools